undamentalytics Newsletter

Our variants

Insider buying: Dollar value bought, 500 largest, traded next day

Backtest from 1 Apr 2010 to 2 Nov 2026 · weekly · hypothetical

Watch this strategy
Return a year
+12.2%
S&P 500 +13.8%
Last 12 months
+14.8%
S&P 500 +12.1%
Sharpe ratio
0.56
S&P 500 0.79
Biggest drop
−44.8%
S&P 500 −31.8%
$10.0k$20.0k$40.0k$80.0k 201020122014201620182020202220242026 $85.9k$67.6k
StrategyS&P 500 $10,000 in Insider buying: Dollar value bought, 500 largest, traded next day from 1 Apr 2010 against the S&P 500 (total return) over the same dates, marked weekly, log scale. Hypothetical: before taxes.

About

Each month, buys the companies whose insiders (officers, directors, large holders) made the largest open-market purchases, by the rule in the label, using only Form 4 filings already public at the rebalance. Costs of 10 basis points a trade are deducted.

Insider backtests →

Key statistics

MeasureStrategyS&P 500
Return a year (compound)+12.2%+13.8%
Total return+576%+759%
Last 12 months+14.8%+12.1%
Last 3 months+1.7%—
Last month+2.3%—
This year so far+11.9%—
Volatility a year21.9%16.1%
Sharpe ratio0.560.79
Biggest drop−44.8%−31.8%
Beta to the S&P 5001.141.00
Alpha a year (t-statistic)−2.1% (−0.70)—
Share of weeks up57%—

Sharpe ratio uses returns above the 3-month Treasury bill rate. Alpha is the yearly return left after allowing for the strategy's exposure to the S&P 500 (CAPM); a t-statistic below about 2 means it cannot be told apart from luck.

Insights

CompanyWeightHeld sinceReturn since
AON10.0%——
BABA10.0%——
BSX10.0%——
CRBG10.0%——
INTC10.0%——
ORCL10.0%——
PEP10.0%——
PFE10.0%——
RSG10.0%——
UBER10.0%——

Equal weight at the latest rebalance, rebuilt every month.

PeriodReturn a yearS&P 500SharpeS&P 500Biggest dropBetaAlpha (t)
Whole backtest1 Apr 2010 to 2 Nov 2026+12.2%+13.8%0.560.79−44.8%1.14−2.1% (−0.70)
2018 onwards5 Jan 2018 to 2 Nov 2026+7.8%+13.9%0.320.66−44.8%1.13−5.7% (−1.27)
Last three years3 Nov 2023 to 2 Nov 2026+28.4%+21.8%1.261.16−15.2%0.83+8.5% (1.12)
Last year7 Nov 2025 to 2 Nov 2026+17.2%+14.2%0.790.84−13.1%0.72+6.0% (0.42)
DateCompanyAction
2 Nov 2026PEPBought
2 Nov 2026ORCLBought
1 Oct 2026UBERBought
1 Oct 2026CRBGBought
1 Oct 2026AONBought
1 Oct 2026AMRZBought
1 Sept 2026WELLBought
1 Sept 2026RSGBought
1 Sept 2026PFEBought
1 Sept 2026NDAQBought
1 Sept 2026INTCBought
1 Sept 2026IFFBought
1 Sept 2026FISVBought
1 Sept 2026ECLBought
1 Sept 2026BSXBought
1 Sept 2026BABABought

Dated at the rebalance that made the change.

DateCompanyAction
2 Nov 2026WELLSold
2 Nov 2026AMRZSold
1 Oct 2026NDAQSold
1 Oct 2026IFFSold
1 Oct 2026FISVSold
1 Oct 2026ECLSold

Dated at the rebalance that made the change.

Backtests are hypothetical and use today's listed companies only, which flatters results. Past performance does not predict future returns. This is research, not investment advice. How we backtest